An interventional study of Multicomponent fear of falling intervention in Fear of Falling, sponsored by Eric Lenouvel. Completed at 3 sites in Switzerland. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-26.
Sponsored by Eric Lenouvel · Not applicable, Interventional, and Prevention
Among 143 studies in Motor Activity with a site in Switzerland — 24 open to participants now, 25 under way, none of them phase 3. Motor Activity · Switzerland.
Among the 143 studies in Motor Activity with a site in Switzerland, this one is the 98th largest by enrollment of the 110 interventional ones that give a count, is one of 14 that started in 2022, is one of 102 with no phase, and was the 142nd registered.
9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.
Browse Motor Activity studies →24 of the 143 studies in Motor Activity with a site in Switzerland are open now. Recruiting first, the newest first:
University of Lausanne · Sites in Switzerland
Ages 18–45 · Healthy volunteers
Mona Lichtblau · Sites in Switzerland
University Hospital, Basel, Switzerland · Sites in Switzerland
Ages 18–43 · Women only · Healthy volunteers
Bern University of Applied Sciences · Sites in Switzerland
Ages 18+
St.Gallen University of Applied Sciences · Sites in Switzerland
Ages 18+
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 65 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
143 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 4 · Phase 3 1 · Phase 4 2
First in 2000; this study’s year is marked. 14 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 19 is below the median of 60 across 8,388 interventional studies indexed under Motor Activity.
Median enrollment 60 across the 110 interventional studies, 120 across the 33 observational. Of the 105 that completed or were terminated, 2 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 143 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Eric Lenouvel as lead sponsor.
Eric Lenouvel has 1 study filed under Motor Activity — fewer than ten, so there is no comparison to draw.
4 of the studies in Motor Activity with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07305389Elena TessitoreThe MUSICare Project: Effects of Differentiated Music Exposure on Exercise-Related Affect Among Cardiac Rehabilitation Inpatients | 2027-01-30 |
| NCT07430943Mona LichtblauFeasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation | 2027-02-28 |
| NCT07815366University of ZurichEffectiveness of Eccentric Cycling Exercise in Ambulatory Rehabilitation for Patients With Cardiopulmonary Diseases: A Pragmatic Randomized Controlled Trial | 2027-05-01 |
| NCT07074639Eleftheria GiannouliCognitive-Motor Exergame Training in Frail Adults | 2027-05-31 |
Among the 143 studies in Motor Activity with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Aktiv Gegen Sturzangst (AGES) is a multicomponent group intervention combining cognitive behavioral therapy and structured exercise to address fear of falling in older adults receiving services from assisted living facilities. This single-arm, non-randomized pilot study evaluated the feasibility of implementing AGES in three assisted living facilities in Switzerland and the feasibility of study procedures and outcome measures for a future controlled trial. Nineteen older adults participated in eight weekly group sessions delivered by trained course leaders. Feasibility outcomes included recruitment, retention, course-leader deployment, protocol adherence, completion of clinical outcome measures, and feasibility of contactless LiDAR-based gait assessment.
AGES was developed as an adaptation of multicomponent approaches to fear of falling for use in German-speaking Swiss assisted living facilities. The intervention consisted of eight weekly group sessions of approximately 60 minutes combining cognitive behavioral therapy-based discussion and reflection with structured balance, strength, mobility, and flexibility exercises. Sessions were delivered by trained facility-based course leaders. The pilot primarily assessed the feasibility of recruitment and retention, course-leader training and deployment, intervention delivery, completion of proposed outcome measures, and LiDAR-based gait assessment. Clinical measures included the Falls Efficacy Scale-International (FES-I), World Health Organization-5 Well-Being Index (WHO-5), and Timed Up and Go test (TUG). The study was exploratory and was not designed or powered to establish intervention effectiveness.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants received the AGES intervention, consisting of eight weekly approximately 60-minute group sessions combining cognitive behavioral therapy-based components with structured physical exercises targeting balance, strength, mobility, and flexibility.
Behavioral: Multicomponent fear of falling intervention
Eight weekly group sessions delivered by trained course leaders. Sessions included cognitive behavioral therapy-based discussion and reflection addressing emotions, automatic thoughts, safety behaviors, assumptions, goal setting, and self-management, combined with structured exercises performed in seated or supported-standing positions where appropriate.
Also known as: Aktiv Gegen Sturzangst (AGES)
Course-leader deployment
Number and proportion of trained course leaders who subsequently delivered an AGES intervention group
Time frame: During the 8-week intervention period
Participant retention
Number and proportion of enrolled participants retained through completion of the intervention
Time frame: Baseline to approximately 8 weeks
Completion of clinical outcome measures
Number and proportion of participants providing paired FES-I, WHO-5 and TUG assessments
Time frame: Baseline and approximately 8 weeks
Protocol adherence
Number of delivering course leaders reporting delivery according to the standardized intervention manual without major deviations
Time frame: Through approximately 8 weeks
Feasibility of LiDAR gait assessment
Proportion of participants in whom LiDAR measurement could be acquired and proportion of acquired measurements yielding usable processed gait data
Time frame: At approximately Week 8, toward the end of the 8-week intervention period
Falls Efficacy Scale-International (FES-I)
The Falls Efficacy Scale-International (FES-I) is a 16-item questionnaire assessing concern about falling during physical and social activities. Each item is scored from 1 (not at all concerned) to 4 (very concerned), giving a total score ranging from 16 to 64. Higher scores indicate greater concern about falling and therefore a worse outcome.
Time frame: Baseline and approximately 8 weeks
World Health Organization-5 Well-Being Index (WHO-5)
The World Health Organization-5 Well-Being Index (WHO-5) is a 5-item questionnaire assessing subjective psychological well-being over the previous two weeks. Each item is scored from 0 (at no time) to 5 (all of the time), giving a total raw score ranging from 0 to 25. Higher scores indicate greater psychological well-being and therefore a better outcome.
Time frame: Baseline and approximately 8 weeks
Timed Up and Go (TUG) Test
The Timed Up and Go (TUG) test assesses functional mobility. Participants are timed, in seconds, while standing up from a chair, walking 3 meters, turning, walking back, and sitting down. The outcome is the time required to complete the test. Lower times indicate better functional mobility, whereas higher times indicate worse mobility.
Time frame: Baseline and approximately 8 weeks
Plan to share: Yes — De-identified individual participant data underlying the results reported in the primary publication may be made available to qualified researchers upon reasonable request, subject to institutional approval, ethical and data-protection requirements, and assessment of the risk of participant re-identification.
Supporting information: Study protocol
Time frame: Beginning 6 months after publication of the primary study results and available for 5 years thereafter.
Access criteria: Requests will be considered from qualified researchers submitting a scientifically sound proposal. Access will be subject to review by the study investigators and, where required, the responsible institution or ethics body. Data will be shared only where compatible with participant consent, applicable data-protection requirements, and an acceptable risk of re-identification. A data-use agreement may be required.
Ran from Sep 2022 to primary completion in Dec 2022, 3 months.
Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 3 months is below that.
Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.